90° versus 110° rotation of left double lumen tube for endobronchial intubation: a randomized controlled trial

左侧双腔管旋转90°与110°进行支气管内插管的随机对照试验

阅读:1

Abstract

BACKGROUND: It is conventional that anesthesiologist rotates the left double lumen tube (DLT) 90° counterclockwise when the DLT endobronchial cuff crosses beyond the glottis, with which the success rate of left endobronchial intubation on first attempt is 75.9%. However, the true inclination angle of the left main bronchus is 108.4°, so the first attempt success rate of left bronchial intubation by 110° left DLT rotation would be higher than of 90° left DLT rotation. This study aimed to assess whether the first attempt success rate of left bronchial intubation by 110° left DLT rotation was higher than of 90° left DLT rotation. METHODS: We conducted a randomized controlled study to compare left DLT 90° versus 110° counterclockwise rotation in adult patients intubated left DLT to undergo elective thoracic surgery. We assessed the first attempt left endobronchial intubation success rate and evaluated the airway injuries at 30 min after the starting of surgery by fiberoptic bronchoscopy and intubation complications such as sore throat and hoarseness at the postoperative 24 h. RESULTS: A total of 556 patients (56.4±12.3 years of age; 322 women) were included: 275 patients in 90° group and 281 patients in 110° group. The first attempt success rate of left bronchial intubation by left DLT was 87.9% in the 110° group versus 80.7% in the 90° group (P=0.02). The 110° group had lower rate of postoperative sore throat as well (33.9% versus 45.8%, P=0.005). However, the two group had no statistical difference in carina mucosal injury and postoperative hoarseness. CONCLUSIONS: When the endobronchial cuff passed beyond the glottis, the left DLT 110° rotation increased the success rate of the first left bronchus intubation and reduced the incidence of sore throat in adult patients during thoracic surgery using left DLT. TRIAL REGISTRATION: This study was registered at Chinese Clinical Trial Registry (ChiCTR2100053350) on November 19th, 2021.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。